Keymeulen, Bart <br/><br/>
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.  [electronic resource] 

 -  The New England journal of medicine  Jun 2005 
 - 2598-608 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa043980  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Autoantibodies--blood<br/>Blood Glucose--analysis<br/>C-Peptide--biosynthesis<br/>CD3 Complex--immunology<br/>Child<br/>Diabetes Mellitus, Type 1--blood<br/>Female<br/>Glucose Clamp Technique<br/>Herpesviridae--isolation & purification<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Immunoglobulin G--adverse effects<br/>Insulin--therapeutic use<br/>Islets of Langerhans--drug effects<br/>Male